Peripheral IVL

About Shockwave Medical

Shockwave Medical is a commercial-stage medical device innovator that has developed a novel Intravascular Lithotripsy (IVL) system for disrupting vascular calcium. Founded in 2009 and now part of Johnson & Johnson MedTech, the company's technology addresses a significant unmet need in interventional cardiology and vascular medicine, offering a safer and more predictable alternative to existing treatments for calcified lesions. With established products in coronary and peripheral markets and a clear reimbursement pathway, Shockwave is positioned for continued growth in a large and expanding global market.

Therapeutic Areas